nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—PDE4C—ganglion—peripheral nervous system neoplasm	0.0205	0.146	CbGeAlD
Amlexanox—PDE4C—tongue—peripheral nervous system neoplasm	0.0202	0.144	CbGeAlD
Amlexanox—FGF1—nerve—peripheral nervous system neoplasm	0.0171	0.122	CbGeAlD
Amlexanox—FGF1—ganglion—peripheral nervous system neoplasm	0.0169	0.12	CbGeAlD
Amlexanox—S100A12—trigeminal ganglion—peripheral nervous system neoplasm	0.0133	0.0946	CbGeAlD
Amlexanox—S100A13—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.0118	0.363	CbGdCrCtD
Amlexanox—S100A13—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.0118	0.363	CbGdCrCtD
Amlexanox—S100A13—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.00892	0.275	CbGdCrCtD
Amlexanox—PDE4C—brainstem—peripheral nervous system neoplasm	0.0089	0.0634	CbGeAlD
Amlexanox—FGF1—trigeminal ganglion—peripheral nervous system neoplasm	0.00828	0.059	CbGeAlD
Amlexanox—FGF1—brainstem—peripheral nervous system neoplasm	0.00733	0.0522	CbGeAlD
Amlexanox—Mouth ulceration—Isotretinoin—peripheral nervous system neoplasm	0.0073	0.0354	CcSEcCtD
Amlexanox—Mouth ulceration—Tretinoin—peripheral nervous system neoplasm	0.0073	0.0354	CcSEcCtD
Amlexanox—Mouth ulceration—Melphalan—peripheral nervous system neoplasm	0.0072	0.035	CcSEcCtD
Amlexanox—Mouth ulceration—Dactinomycin—peripheral nervous system neoplasm	0.00597	0.029	CcSEcCtD
Amlexanox—S100A13—cerebellum—peripheral nervous system neoplasm	0.00587	0.0418	CbGeAlD
Amlexanox—Aphthous stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00571	0.0277	CcSEcCtD
Amlexanox—Mouth ulceration—Alitretinoin—peripheral nervous system neoplasm	0.00553	0.0269	CcSEcCtD
Amlexanox—Liver function test abnormal—Melphalan—peripheral nervous system neoplasm	0.00534	0.0259	CcSEcCtD
Amlexanox—Mouth ulceration—Vincristine—peripheral nervous system neoplasm	0.00533	0.0259	CcSEcCtD
Amlexanox—Aphthous stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00528	0.0257	CcSEcCtD
Amlexanox—PDE4B—trigeminal ganglion—peripheral nervous system neoplasm	0.00467	0.0333	CbGeAlD
Amlexanox—Stomatitis—Topotecan—peripheral nervous system neoplasm	0.00444	0.0215	CcSEcCtD
Amlexanox—Liver function test abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00442	0.0215	CcSEcCtD
Amlexanox—PDE4B—parotid gland—peripheral nervous system neoplasm	0.0044	0.0314	CbGeAlD
Amlexanox—Stomatitis—Tretinoin—peripheral nervous system neoplasm	0.0044	0.0214	CcSEcCtD
Amlexanox—Stomatitis—Isotretinoin—peripheral nervous system neoplasm	0.0044	0.0214	CcSEcCtD
Amlexanox—Stomatitis—Melphalan—peripheral nervous system neoplasm	0.00435	0.0211	CcSEcCtD
Amlexanox—Mouth ulceration—Etoposide—peripheral nervous system neoplasm	0.00432	0.021	CcSEcCtD
Amlexanox—PDE4D—cerebellum—peripheral nervous system neoplasm	0.00386	0.0275	CbGeAlD
Amlexanox—FGF1—cerebellum—peripheral nervous system neoplasm	0.00361	0.0257	CbGeAlD
Amlexanox—Stomatitis—Dactinomycin—peripheral nervous system neoplasm	0.0036	0.0175	CcSEcCtD
Amlexanox—PDE4A—cerebellum—peripheral nervous system neoplasm	0.00342	0.0244	CbGeAlD
Amlexanox—Stomatitis—Alitretinoin—peripheral nervous system neoplasm	0.00334	0.0162	CcSEcCtD
Amlexanox—Stomatitis—Vincristine—peripheral nervous system neoplasm	0.00321	0.0156	CcSEcCtD
Amlexanox—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00285	0.0138	CcSEcCtD
Amlexanox—Stomatitis—Cisplatin—peripheral nervous system neoplasm	0.00284	0.0138	CcSEcCtD
Amlexanox—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00282	0.0137	CcSEcCtD
Amlexanox—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00282	0.0137	CcSEcCtD
Amlexanox—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00261	0.0127	CcSEcCtD
Amlexanox—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.0026	0.0126	CcSEcCtD
Amlexanox—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00259	0.0126	CcSEcCtD
Amlexanox—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00259	0.0126	CcSEcCtD
Amlexanox—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00255	0.0124	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00251	0.0122	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00249	0.0121	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00249	0.0121	CcSEcCtD
Amlexanox—Pain—Topotecan—peripheral nervous system neoplasm	0.00248	0.0121	CcSEcCtD
Amlexanox—Pain—Tretinoin—peripheral nervous system neoplasm	0.00246	0.012	CcSEcCtD
Amlexanox—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00246	0.012	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00245	0.0119	CcSEcCtD
Amlexanox—Pain—Melphalan—peripheral nervous system neoplasm	0.00243	0.0118	CcSEcCtD
Amlexanox—Mouth ulceration—Epirubicin—peripheral nervous system neoplasm	0.00242	0.0118	CcSEcCtD
Amlexanox—Mouth ulceration—Doxorubicin—peripheral nervous system neoplasm	0.00224	0.0109	CcSEcCtD
Amlexanox—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00214	0.0104	CcSEcCtD
Amlexanox—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00206	0.01	CcSEcCtD
Amlexanox—PDE4B—cerebellum—peripheral nervous system neoplasm	0.00204	0.0145	CbGeAlD
Amlexanox—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00201	0.00978	CcSEcCtD
Amlexanox—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00196	0.00952	CcSEcCtD
Amlexanox—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00189	0.00917	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00915	CcSEcCtD
Amlexanox—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00187	0.00906	CcSEcCtD
Amlexanox—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00182	0.00886	CcSEcCtD
Amlexanox—Headache—Topotecan—peripheral nervous system neoplasm	0.00182	0.00883	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00182	0.00882	CcSEcCtD
Amlexanox—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0018	0.00876	CcSEcCtD
Amlexanox—Headache—Tretinoin—peripheral nervous system neoplasm	0.0018	0.00876	CcSEcCtD
Amlexanox—Pain—Vincristine—peripheral nervous system neoplasm	0.0018	0.00873	CcSEcCtD
Amlexanox—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00871	CcSEcCtD
Amlexanox—Nausea—Topotecan—peripheral nervous system neoplasm	0.00172	0.00837	CcSEcCtD
Amlexanox—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00171	0.00831	CcSEcCtD
Amlexanox—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00171	0.00831	CcSEcCtD
Amlexanox—Nausea—Melphalan—peripheral nervous system neoplasm	0.00169	0.0082	CcSEcCtD
Amlexanox—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00167	0.00811	CcSEcCtD
Amlexanox—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00806	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00161	0.0078	CcSEcCtD
Amlexanox—Pain—Cisplatin—peripheral nervous system neoplasm	0.00159	0.00772	CcSEcCtD
Amlexanox—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00153	0.00743	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00147	0.00714	CcSEcCtD
Amlexanox—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00709	CcSEcCtD
Amlexanox—Pain—Etoposide—peripheral nervous system neoplasm	0.00146	0.00708	CcSEcCtD
Amlexanox—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0014	0.00679	CcSEcCtD
Amlexanox—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00664	CcSEcCtD
Amlexanox—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00656	CcSEcCtD
Amlexanox—Headache—Vincristine—peripheral nervous system neoplasm	0.00132	0.0064	CcSEcCtD
Amlexanox—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.0063	CcSEcCtD
Amlexanox—Nausea—Vincristine—peripheral nervous system neoplasm	0.00125	0.00607	CcSEcCtD
Amlexanox—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00536	CcSEcCtD
Amlexanox—Headache—Etoposide—peripheral nervous system neoplasm	0.00107	0.00518	CcSEcCtD
Amlexanox—Nausea—Etoposide—peripheral nervous system neoplasm	0.00101	0.00491	CcSEcCtD
Amlexanox—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000937	0.00455	CcSEcCtD
Amlexanox—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000867	0.00421	CcSEcCtD
Amlexanox—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000858	0.00416	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000825	0.004	CcSEcCtD
Amlexanox—Pain—Epirubicin—peripheral nervous system neoplasm	0.000817	0.00397	CcSEcCtD
Amlexanox—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000794	0.00385	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000763	0.0037	CcSEcCtD
Amlexanox—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000756	0.00367	CcSEcCtD
Amlexanox—S100A12—Immune System—IFNB1—peripheral nervous system neoplasm	0.000624	0.001	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	0.000621	0.001	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—AKT1—peripheral nervous system neoplasm	0.000614	0.000988	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—NRAS—peripheral nervous system neoplasm	0.000612	0.000985	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	0.000612	0.000985	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000612	0.000985	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	0.000604	0.000973	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000604	0.000972	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000603	0.000971	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.000603	0.00097	CbGpPWpGaD
Amlexanox—IL3—Immune System—HGF—peripheral nervous system neoplasm	0.000601	0.000967	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000599	0.000964	CbGpPWpGaD
Amlexanox—Headache—Epirubicin—peripheral nervous system neoplasm	0.000598	0.00291	CcSEcCtD
Amlexanox—IL3—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	0.00059	0.00095	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000579	0.000932	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—NRAS—peripheral nervous system neoplasm	0.000575	0.000926	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—NRAS—peripheral nervous system neoplasm	0.000573	0.000922	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	0.00057	0.000917	CbGpPWpGaD
Amlexanox—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000567	0.00275	CcSEcCtD
Amlexanox—FGF1—DAP12 signaling—NRAS—peripheral nervous system neoplasm	0.000567	0.000913	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—NRAS—peripheral nervous system neoplasm	0.000559	0.0009	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000557	0.000897	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000555	0.000893	CbGpPWpGaD
Amlexanox—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.00269	CcSEcCtD
Amlexanox—FGF1—PI-3K cascade—AKT1—peripheral nervous system neoplasm	0.000553	0.00089	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000551	0.000887	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—HRAS—peripheral nervous system neoplasm	0.000547	0.000881	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000545	0.000878	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—AKT1—peripheral nervous system neoplasm	0.00054	0.000869	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—AKT1—peripheral nervous system neoplasm	0.000536	0.000862	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD34—peripheral nervous system neoplasm	0.000534	0.00086	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—NRAS—peripheral nervous system neoplasm	0.000533	0.000859	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	0.000533	0.000859	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	0.000533	0.000859	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	0.000529	0.000851	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000528	0.00085	CbGpPWpGaD
Amlexanox—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.00255	CcSEcCtD
Amlexanox—FGF1—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.000524	0.000843	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—peripheral nervous system neoplasm	0.000523	0.000842	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	0.000522	0.00084	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000514	0.000828	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00051	0.000821	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000506	0.000814	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000504	0.000811	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000503	0.000809	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—NRAS—peripheral nervous system neoplasm	0.000494	0.000795	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000489	0.000787	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000487	0.000784	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000485	0.00078	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HGF—peripheral nervous system neoplasm	0.000482	0.000775	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00048	0.000772	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000478	0.000769	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000477	0.000767	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000475	0.000765	CbGpPWpGaD
Amlexanox—FGF1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000475	0.000764	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000473	0.00076	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.000468	0.000753	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000468	0.000753	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000466	0.000751	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000465	0.000749	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000462	0.000743	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000456	0.000734	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NCAM1—peripheral nervous system neoplasm	0.000454	0.000731	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	0.000448	0.000721	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000444	0.000715	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000442	0.000712	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000441	0.00071	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00044	0.000709	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000439	0.000706	CbGpPWpGaD
Amlexanox—IL3—Immune System—PTPN11—peripheral nervous system neoplasm	0.000438	0.000706	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000434	0.000698	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000427	0.000687	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000424	0.000682	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	0.000421	0.000678	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000419	0.000675	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	0.000419	0.000674	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000418	0.000672	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000417	0.000671	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—HRAS—peripheral nervous system neoplasm	0.000415	0.000668	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.000413	0.000665	CbGpPWpGaD
Amlexanox—FGF1—Disease—ENO2—peripheral nervous system neoplasm	0.000411	0.000662	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	0.000409	0.000658	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000408	0.000656	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000405	0.000652	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000404	0.00065	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	0.000396	0.000637	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	0.00039	0.000628	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—HRAS—peripheral nervous system neoplasm	0.00039	0.000628	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	0.00039	0.000628	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.000389	0.000626	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000388	0.000624	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	0.000387	0.000623	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000386	0.000622	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000385	0.00062	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000385	0.00062	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—peripheral nervous system neoplasm	0.000385	0.000619	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000384	0.000618	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000383	0.000617	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	0.000382	0.000614	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000373	0.000601	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	0.000372	0.000598	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	0.00037	0.000595	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000368	0.000592	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000368	0.000592	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000367	0.00059	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—AKT1—peripheral nervous system neoplasm	0.000366	0.00059	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000363	0.000585	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000363	0.000584	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000361	0.000581	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000361	0.000581	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00036	0.00058	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000357	0.000574	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNB1—peripheral nervous system neoplasm	0.000356	0.000574	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PTPN11—peripheral nervous system neoplasm	0.000351	0.000565	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000349	0.000562	CbGpPWpGaD
Amlexanox—IL3—Immune System—ERBB2—peripheral nervous system neoplasm	0.000346	0.000558	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000346	0.000556	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000345	0.000555	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.000345	0.000555	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.000345	0.000555	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.000345	0.000555	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.000342	0.00055	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000339	0.000546	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000339	0.000545	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000337	0.000542	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000333	0.000535	CbGpPWpGaD
Amlexanox—FGF1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000332	0.000534	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000331	0.000533	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000325	0.000523	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000324	0.000522	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000319	0.000513	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000307	0.000495	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000305	0.000491	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000304	0.000489	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000299	0.000481	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000289	0.000466	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000288	0.000464	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000285	0.000458	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000283	0.000456	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ERBB2—peripheral nervous system neoplasm	0.000278	0.000447	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HGF—peripheral nervous system neoplasm	0.000275	0.000443	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000272	0.000439	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000268	0.000431	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000268	0.000431	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000266	0.000428	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000265	0.000427	CbGpPWpGaD
Amlexanox—IL3—Immune System—NRAS—peripheral nervous system neoplasm	0.000264	0.000424	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	0.000262	0.000421	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000261	0.000421	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00026	0.000419	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000255	0.00041	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00025	0.000402	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000248	0.000399	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000248	0.000399	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000236	0.00038	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000236	0.000379	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000235	0.000378	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000234	0.000377	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000229	0.000369	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000227	0.000366	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000224	0.000361	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000218	0.000351	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000217	0.000348	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000214	0.000344	CbGpPWpGaD
Amlexanox—S100A12—Immune System—NRAS—peripheral nervous system neoplasm	0.000211	0.00034	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000211	0.00034	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000207	0.000334	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000205	0.00033	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000204	0.000328	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000203	0.000327	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PTPN11—peripheral nervous system neoplasm	0.000201	0.000323	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.0002	0.000322	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	0.000199	0.00032	CbGpPWpGaD
Amlexanox—IL3—Immune System—HRAS—peripheral nervous system neoplasm	0.000193	0.00031	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000187	0.000301	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000186	0.0003	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTPN11—peripheral nervous system neoplasm	0.000185	0.000298	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000185	0.000297	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000182	0.000292	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00017	0.000274	CbGpPWpGaD
Amlexanox—IL3—Immune System—AKT1—peripheral nervous system neoplasm	0.00017	0.000274	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000161	0.000259	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000159	0.000255	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ERBB2—peripheral nervous system neoplasm	0.000159	0.000255	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000158	0.000254	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HRAS—peripheral nervous system neoplasm	0.000155	0.000249	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000153	0.000246	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000152	0.000244	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00015	0.000242	CbGpPWpGaD
Amlexanox—FGF1—Disease—ERBB2—peripheral nervous system neoplasm	0.000147	0.000236	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	0.000146	0.000234	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000144	0.000231	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000142	0.000228	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000139	0.000224	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AKT1—peripheral nervous system neoplasm	0.000136	0.00022	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000135	0.000218	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000134	0.000216	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000131	0.000212	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.00013	0.00021	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00013	0.00021	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00013	0.000209	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	0.000129	0.000207	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000125	0.000201	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000125	0.000201	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NRAS—peripheral nervous system neoplasm	0.000121	0.000194	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000119	0.000192	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000119	0.000191	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000118	0.000189	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000114	0.000184	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000113	0.000183	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000112	0.00018	CbGpPWpGaD
Amlexanox—FGF1—Disease—NRAS—peripheral nervous system neoplasm	0.000111	0.000179	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.00011	0.000177	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00011	0.000177	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000109	0.000176	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000109	0.000175	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000108	0.000174	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000104	0.000167	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—peripheral nervous system neoplasm	0.000104	0.000167	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000104	0.000167	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000103	0.000165	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000102	0.000164	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000101	0.000162	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.99e-05	0.000161	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.89e-05	0.000159	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.51e-05	0.000153	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.31e-05	0.00015	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.15e-05	0.000147	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.05e-05	0.000146	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.85e-05	0.000142	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HRAS—peripheral nervous system neoplasm	8.83e-05	0.000142	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.43e-05	0.000136	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.37e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.35e-05	0.000134	CbGpPWpGaD
Amlexanox—FGF1—Disease—HRAS—peripheral nervous system neoplasm	8.15e-05	0.000131	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.99e-05	0.000129	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.81e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AKT1—peripheral nervous system neoplasm	7.8e-05	0.000126	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.8e-05	0.000126	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.27e-05	0.000117	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.27e-05	0.000117	CbGpPWpGaD
Amlexanox—FGF1—Disease—AKT1—peripheral nervous system neoplasm	7.2e-05	0.000116	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.05e-05	0.000114	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.95e-05	0.000112	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.92e-05	0.000111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.62e-05	0.000107	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.4e-05	0.000103	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.14e-05	9.88e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.12e-05	9.86e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.97e-05	9.61e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.84e-05	9.41e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.71e-05	9.19e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.41e-05	8.7e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.04e-05	8.12e-05	CbGpPWpGaD
